154.7K XNAS Volume
XNAS 05 Jun, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Ora H. Pescovitz | Director | Purchase of securities on an exchange or from another person at price $ 5.89 per share. | 08 Apr 2025 | 7,693 | 24,329 | - | 5.9 | 45,312 | Common Stock |
| Stephen L. Hoerter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2025 | 32,000 | 32,000 | - | - | Stock option (right to buy) | |
| Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.84 per share. | 14 Feb 2025 | 94,100 | 747,887 | - | 10.8 | 1,020,044 | Common Stock |
| Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.84 per share. | 14 Feb 2025 | 49,070 | 3,255,000 | - | 10.8 | 531,919 | Common Stock |
| Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.85 per share. | 14 Feb 2025 | 29,540 | 3,205,930 | - | 9.9 | 290,969 | Common Stock |
| Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.90 per share. | 14 Feb 2025 | 17,962 | 3,176,390 | - | 9.9 | 177,824 | Common Stock |
| Peter Kent Hawryluk | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 10.69 per share. | 03 Feb 2025 | 50,000 | 448,277 | - | 10.7 | 534,500 | Common Stock |
| Richard B. Bartram | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 95,000 | 95,000 | - | - | Stock Option (Right to Buy) | |
| Peter Kent Hawryluk | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 243,000 | 243,000 | - | - | Stock Option (Right to Buy) | |
| Salomon Azoulay | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Patrick J. Heron | Director, Ten Percent Owner | 16 Sep 2024 | 3,927,774 | 3,927,774 | - | - | Common Stock | ||
| James M. Cornelius | Director | 16 Sep 2024 | 102,082 | 102,082 | - | - | Common Stock | ||
| Patrick J. Heron | Director, Ten Percent Owner | 16 Sep 2024 | 18,922,852 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Patrick J. Heron | Director, Ten Percent Owner | 16 Sep 2024 | 28,297,265 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Patrick J. Heron | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 16 Sep 2024 | 625,000 | 4,552,774 | - | 16 | 10,000,000 | Common Stock |
| Peter Kent Hawryluk | Director, President & CEO | 16 Sep 2024 | 1,396,762 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Peter Kent Hawryluk | Director, President & CEO | 16 Sep 2024 | 345,705 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Peter Kent Hawryluk | Director, President & CEO | 16 Sep 2024 | 283,846 | 481,397 | - | - | Common Stock | ||
| Peter Kent Hawryluk | Director, President & CEO | 16 Sep 2024 | 115,914 | 398,277 | - | - | Common Stock | ||
| Peter Kent Hawryluk | Director, President & CEO | 16 Sep 2024 | 2,015,681 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Peter Kent Hawryluk | Director, President & CEO | 16 Sep 2024 | 970,873 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Peter Kent Hawryluk | Director, President & CEO | 16 Sep 2024 | 76,969 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Tiba Aynechi | Director | 16 Sep 2024 | 1,386,335 | 1,386,335 | - | - | Common Stock | ||
| Tiba Aynechi | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 16 Sep 2024 | 750,000 | 2,136,335 | - | 16 | 12,000,000 | Common Stock |
| Tiba Aynechi | Director | 16 Sep 2024 | 16,666,666 | 0 | - | - | Series B Convertible Preferred Stock | ||
| James M. Cornelius | Director | 16 Sep 2024 | 994,069 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Carl L. Gordon | Director, Ten Percent Owner | 16 Sep 2024 | 19,587,284 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Carl L. Gordon | Director, Ten Percent Owner | 16 Sep 2024 | 12,372,634 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 16 Sep 2024 | 250,000 | 653,787 | - | 16 | 4,000,000 | Common Stock |
| Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 16 Sep 2024 | 500,000 | 3,158,428 | - | 16 | 8,000,000 | Common Stock |
| Carl L. Gordon | Director, Ten Percent Owner | 16 Sep 2024 | 403,787 | 403,787 | - | - | Common Stock | ||
| Carl L. Gordon | Director, Ten Percent Owner | 16 Sep 2024 | 2,658,428 | 2,658,428 | - | - | Common Stock | ||
| Carl L. Gordon | Director, Ten Percent Owner | 16 Sep 2024 | 4,854,368 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Edward T. Mathers | Director, Ten Percent Owner | 16 Sep 2024 | 25,142,840 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Edward T. Mathers | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 16 Sep 2024 | 500,000 | 3,614,486 | - | 16 | 8,000,000 | Common Stock |
| Edward T. Mathers | Director, Ten Percent Owner | 16 Sep 2024 | 2,091,383 | 3,114,486 | - | - | Common Stock | ||
| Edward T. Mathers | Director, Ten Percent Owner | 16 Sep 2024 | 1,023,103 | 1,023,103 | - | - | Common Stock | ||
| Edward T. Mathers | Director, Ten Percent Owner | 16 Sep 2024 | 12,299,854 | 0 | - | - | Series A Convertible Preferred Stock | ||
| James M. Cornelius | Director | 16 Sep 2024 | 233,192 | 0 | - | - | Series B Convertible Preferred Stock | ||
| James M. Cornelius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 15,963 | 15,963 | - | - | Stock Option (Right to Buy) | |
| Salomon Azoulay | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 45,011 | 45,011 | - | - | Stock Option (Right to Buy) | |
| Steven Ryder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 15,963 | 15,963 | - | - | Stock Option (Right to Buy) | |
| Peter Kent Hawryluk | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 120,436 | 120,436 | - | - | Stock Option (Right to Buy) | |
| Richard B. Bartram | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 42,578 | 42,578 | - | - | Stock Option (Right to Buy) | |
| Edward T. Mathers | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 15,963 | 15,963 | - | - | Stock Option (Right to Buy) | |
| Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 15,963 | 15,963 | - | - | Stock Option (Right to Buy) | |
| Tiba Aynechi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 15,963 | 15,963 | - | - | Stock Option (Right to Buy) | |
| Ora H. Pescovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 15,963 | 15,963 | - | - | Stock Option (Right to Buy) | |
| Patrick J. Heron | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 15,963 | 15,963 | - | - | Stock Option (Right to Buy) |